Ciprofloxacin Tablet, Film Coated
Product Images NDC 16571-413

9 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 16571-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adult Dosage Guidelines (Adult Dosage Guidelines)

Adult Dosage Guidelines (Adult Dosage Guidelines)
A dosing regimen table for ciprofloxacin tablets, detailing infection types, recommended dose ranges (250 mg to 750 mg), frequency of administration (mostly every 12 hours), and usual treatment durations ranging from single dose to 60 days for various infections including skin, bone, gastrointestinal, respiratory, and urinary tract.*
FDA Label Image

Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)

Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)
A data table titled 'Pediatric Dosage Guidelines' showing ciprofloxacin dosing information for three infections: complicated urinary tract or pyelonephritis for patients 1 to 17 years old, inhalational anthrax post-exposure, and plague. The table details dose, frequency, and total duration for each condition.*
FDA Label Image

Ciprofloxacin-str1 (Ciprofloxacin Str1)

Ciprofloxacin-str1 (Ciprofloxacin Str1)
Chemical structure of ciprofloxacin hydrochloride monohydrate, showing its molecular formula with characteristic fluorine, piperazine, and carboxyl groups.*
FDA Label Image

Steady Pharmacokinetic (Steady Pharmacokinetic)

Steady Pharmacokinetic (Steady Pharmacokinetic)
A data table titled 'Steady-state Pharmacokinetic Parameters Following Multiple Oral and Intravenous Doses (Adults)' showing parameters for ciprofloxacin doses of 500 mg orally every 12 hours, 400 mg intravenously every 12 hours, 750 mg orally every 12 hours, and 400 mg intravenously every 8 hours. The table includes AUC (μg•h/mL) and Cmax (μg/mL) values for each dosing regimen.*
FDA Label Image
FDA Label Image

250100tabs (250100tabs)

250100tabs (250100tabs)
Label for Ciprofloxacin Tablets USP 250 mg film-coated tablets by Rising Pharmaceuticals. The package contains 100 tablets, marked Rx only, with storage instructions and manufacturer details from Unique Pharmaceuticals & A Div. of U.B. Chemicals & Pharmaceuticals Ltd., India. Distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ.*
FDA Label Image

500500tabs (500500tabs)

500500tabs (500500tabs)
Label for Ciprofloxacin Tablets USP 500 mg by Rising Pharmaceuticals. The film-coated oral tablets come in a package of 500 tablets. The label includes storage instructions, bar code, manufacturing and distribution information, and directs pharmacists to dispense with a separate medication guide.*
FDA Label Image

500100tabs (500100tabs)

500100tabs (500100tabs)
Label for Ciprofloxacin Tablets USP 500 mg film-coated tablets by Rising Pharma Holdings, Inc. The package contains 100 tablets. It displays the NDC 16571-412-10, instructions to dispense with a medication guide, and storage conditions. Manufacturer and distributor information is also included, along with a barcode and a link to the medication guide PDF.*
FDA Label Image

75050tabs (75050tabs)

75050tabs (75050tabs)
Label for Ciprofloxacin Tablets USP 750 mg film-coated tablets by Rising Pharmaceutical. The carton holds 50 tablets and includes instructions to dispense with a medication guide. The label shows NDC 16571-413-05 and distribution information. It is marked Rx only and includes storage and dosing guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.